Common pitfalls and issues during generic licensing negotiations.

This paper is about the key points of debate in generic licensing agreements, considering the objectives of the licensor and licensee. It offers compromise solutions that should help business development professionals in the generic industry in the portion of their job requiring negotiations as licensor and licensee, with the common objective to bring affordable medicines to those who need them, while increasing profits.Journal of Generic Medicines (2007) 4, 180–185. doi:10.1057/palgrave.jgm.4950069 [ABSTRACT FROM AUTHOR]